| Kasi Viswanatha Raju Chekuri, MD | |
|
1202 3rd St, Corpus Christi, TX 78404-2314 | |
| (361) 883-3962 | |
| (361) 883-5398 |
| Full Name | Kasi Viswanatha Raju Chekuri |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 26 Years |
| Location | 1202 3rd St, Corpus Christi, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093797193 | NPI | - | NPPES |
| 0-601-314-8 | Other | ECFMG |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | M0375 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Spohn Hospital Corpus Christi | Corpus christi, TX | Hospital |
| Corpus Christi Medical Center,the | Corpus christi, TX | Hospital |
| Christus Spohn Hospital Beeville | Beeville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Corpus Christi Heart Clinic, Pllc | 2163726746 | 7 |
News Archive
A novel microarray-based 18-gene expression tool known as ColoPrint significantly improves prognostic accuracy in stage II colon cancer patients who have undergone surgery, suggest study findings.
AcelRx Pharmaceuticals, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
"Chief Information Officers (CIOs) need to perform a gap analysis to identify where Information Technology (IT) needs to be, from a business and not an IT perspective," advises Greg Johnson, Chief Technology Officer at the Virginia Commonwealth University Health System. Healthcare organizations must be able to work smart, which means that virtualization, standardization and simplification of the IT environment are necessary for meeting growing organizational goals.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $3.5 million from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to accelerate development of a new class of anti-diabetic compounds.
› Verified 3 days ago
| Entity Name | Corpus Christi Heart Clinic, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326415035 PECOS PAC ID: 2163726746 Enrollment ID: O20160202000099 |
News Archive
A novel microarray-based 18-gene expression tool known as ColoPrint significantly improves prognostic accuracy in stage II colon cancer patients who have undergone surgery, suggest study findings.
AcelRx Pharmaceuticals, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
"Chief Information Officers (CIOs) need to perform a gap analysis to identify where Information Technology (IT) needs to be, from a business and not an IT perspective," advises Greg Johnson, Chief Technology Officer at the Virginia Commonwealth University Health System. Healthcare organizations must be able to work smart, which means that virtualization, standardization and simplification of the IT environment are necessary for meeting growing organizational goals.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $3.5 million from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to accelerate development of a new class of anti-diabetic compounds.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kasi Viswanatha Raju Chekuri, MD 1202 3rd St, Corpus Christi, TX 78404-2314 Ph: (361) 883-3962 | Kasi Viswanatha Raju Chekuri, MD 1202 3rd St, Corpus Christi, TX 78404-2314 Ph: (361) 883-3962 |
News Archive
A novel microarray-based 18-gene expression tool known as ColoPrint significantly improves prognostic accuracy in stage II colon cancer patients who have undergone surgery, suggest study findings.
AcelRx Pharmaceuticals, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its common stock. All shares of the common stock to be sold in the offering will be offered by the Company.
"Chief Information Officers (CIOs) need to perform a gap analysis to identify where Information Technology (IT) needs to be, from a business and not an IT perspective," advises Greg Johnson, Chief Technology Officer at the Virginia Commonwealth University Health System. Healthcare organizations must be able to work smart, which means that virtualization, standardization and simplification of the IT environment are necessary for meeting growing organizational goals.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $3.5 million from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to accelerate development of a new class of anti-diabetic compounds.
› Verified 3 days ago
Dr. Natalie W Philbrick, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3301 S Alameda St Ste 201, Corpus Christi, TX 78411 Phone: 361-857-2900 | |
Dr. Gregg Lee Silverman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 613 Elizabeth St, Suite 402, Corpus Christi, TX 78404 Phone: 361-887-2900 Fax: 361-887-0942 | |
Dr. Stanley Cal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4918 Ayers St Ste 130, Corpus Christi, TX 78415 Phone: 361-400-4355 Fax: 888-815-1095 | |
James Michael Neff, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 7121 S Padre Island Dr, Corpus Christi, TX 78412 Phone: 361-696-6200 Fax: 361-696-6054 | |
Dr. John Douglas Pappas, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1521 S Staples St Ste 700, Corpus Christi, TX 78404 Phone: 361-888-8271 Fax: 361-885-3699 | |
Thomas Alexander, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1202 3rd St, Corpus Christi, TX 78404 Phone: 361-883-3962 Fax: 361-883-5398 | |
Marie Charisse Impe, NP Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5802 Saratoga Blvd Ste 200, Corpus Christi, TX 78414 Phone: 361-696-6200 |